MAPK3 and breast carcinoma: To determine whether ADAM8 leads to ERK activation in breast cancer cells, we tested ERK1/2 phosphorylation (p44/p42) levels in Hs578T cells that overexpress ADAM8 naturally when cultured under 3D conditions versus 2D, as shown above in Fig. 2g.